giovedì 18 agosto 2011

VGF4.8 peptide potrebbe essere

un nuovo marker per le condizioni

degenerative del cervello

L'espressione di VGF4.8 è stato segnalato per essere ridotta in patologicamente alterazioni degenerative come il morbo di Alzheimer, la sclerosi laterale amiotrofica (SLA),

la demenza frontotemporale, ed encefalopatia.

1 commento:

Fabio e Fabrizio ha detto...

2011 Aug 12;11(1):101. [Epub ahead of print]
Identification of a novel biomarker candidate, a 4.8-kDa peptide fragment from a neurosecretory protein VGF precursor, by proteomic analysis of cerebrospinal fluid from children with acute encephalopathy using SELDI-TOF-MS.
Asano T, Koizumi S, Takagi A, Hatori T, Kuwabara K, Fujino O, Fukunaga Y.

BACKGROUND: Acute encephalopathy includes rapid deterioration and has a poor prognosis. Early intervention is essential to prevent progression of the disease and subsequent neurologic complications. However, in the acute period, true encephalopathy cannot easily be differentiated from febrile seizures, especially febrile seizures of the complex type. Thus, an early diagnostic marker has been sought in order to enable early intervention. The purpose of this study was to identify a novel marker candidate protein differentially expressed in the cerebrospinal fluid (CSF) of children with encephalopathy using proteomic analysis.

METHODS: For detection of biomarkers, CSF samples were obtained from 13 children with acute encephalopathy and 42 children with febrile seizure. Mass spectral data were generated by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) technology, which is currently applied in many fields of biological and medical sciences. Diagnosis was made by at least two pediatric neurologists based on the clinical findings and routine examinations. All specimens were collected for diagnostic tests and the remaining portion of the specimens were used for the SELDI-TOF MS investigations.

RESULTS: In experiment 1, CSF from patients with febrile seizures (n=28), patients with encephalopathy (n=8) (including influenza encephalopathy (n=3), encephalopathy due to rotavirus (n=1), human herpes virus 6 (n=1)) and patients with fever without neurological involvement such as convulsions (n=11) were used for the SELDI analysis. In experiment 2, SELDI analysis was performed on CSF from a second set of febrile seizure patients (n=14) and encephalopathy patients (n=5). We found that the peak with an m/z of 4810 contributed the most to the separation of the two groups. After purification and identification of the 4.8-kDa protein, a 4.8-kDa proteolytic peptide fragment from the neurosecretory protein VGF precursor (VGF4.8) was identified as a novel biomarker for encephalopathy.

CONCLUSIONS: Expression of VGF4.8 has been reported to be decreased in pathologically degenerative changes such as Alzheimer's disease, amyotrophic lateral sclerosis (ALS), frontotemporal dementia, and encephalopathy. Thus, the VGF4.8 peptide might be a novel marker for degenerative brain conditions.

PMID: 21838886 [PubMed - as supplied by publisher